Pediatrix Medical Group (NYSE:MD) Stock Price Up 7.1% on Analyst Upgrade

Pediatrix Medical Group, Inc. (NYSE:MD) traded up 7.1% during mid-day trading on Wednesday after Truist Financial raised their price target on the stock from $23.00 to $28.00. Truist Financial currently has a hold rating on the stock. Pediatrix Medical Group traded as high as $25.26 and last traded at $25.8260. 177,002 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 800,942 shares. The stock had previously closed at $24.11.

Other equities research analysts also recently issued reports about the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Wednesday, June 24th. UBS Group boosted their price objective on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $27.00 price objective on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Finally, Mizuho set a $24.00 price objective on Pediatrix Medical Group in a research report on Friday, May 8th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $23.33.

Insider Buying and Selling

In other Pediatrix Medical Group news, Director Shirley A. Weis sold 36,028 shares of the company’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a filing with the SEC, which is available through this link. 1.80% of the stock is owned by corporate insiders.

Institutional Trading of Pediatrix Medical Group

Large investors have recently modified their holdings of the company. Global Retirement Partners LLC increased its holdings in Pediatrix Medical Group by 68,250.0% during the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after purchasing an additional 1,365 shares during the period. Transamerica Financial Advisors LLC bought a new stake in Pediatrix Medical Group during the 4th quarter valued at $30,000. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Pediatrix Medical Group in the 4th quarter worth $33,000. Blue Trust Inc. purchased a new stake in shares of Pediatrix Medical Group in the 4th quarter worth $37,000. Finally, TD Private Client Wealth LLC bought a new position in shares of Pediatrix Medical Group during the 4th quarter worth $39,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Up 1.6%

The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The business has a 50-day moving average price of $23.86 and a 200-day moving average price of $22.16. The firm has a market cap of $2.16 billion, a P/E ratio of 12.76 and a beta of 0.66.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The firm had revenue of $476.20 million during the quarter, compared to the consensus estimate of $465.83 million. During the same period in the previous year, the company posted $0.33 earnings per share. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. On average, equities analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.